The Blood Lactate/serum Albumin Ratio Might Represent a Good Prognostic Indicator of 28-Day Mortality in Patients with Acute Respiratory Distress Syndrome:A Retrospective Observational Study
Jiahao Chen,Chang Gao,Ling Yang,Lijuan Yang,Ying He,Shiqi Guo,Yuanxiao Sun,Siyu He,Qiang Guo
DOI: https://doi.org/10.1097/ec9.0000000000000105
2024-01-01
Emergency and Critical Care Medicine
Abstract:Background:Acute respiratory distress syndrome(ARDS)is an acute inflammatory lung injury with a high mortality rate.However,pre-vious ARDS prognostic scoring systems or predictors have been limited by complex formulas that are relatively expensive and inconve-nient to obtain.Thus,this study aimed to explore the clinical significance of the blood lactate/serum albumin ratio(LAR)in assessing the prognosis of ARDS patients and compare it with other indicators related to 28-day mortality in ARDS patients. Methods:We conducted a single-center retrospective study involving patients who fulfilled the Berlin definition of ARDS between 2016 and 2021.Clinical data were collected from medical records within 24 hours after ARDS diagnosis.The LAR,neutrophil-to-lymphocyte ratio,and monocyte-to-lymphocyte ratio(MLR)were calculated.The primary clinical outcome was 28-day mortality.The risk factors for 28-day mortality were determined using conditional logistic regression analysis.The receiver operating characteristic curve was used to evaluate the area under the curve(AUC). Results:A total of 276 ARDS patients met the inclusion criteria and were divided into surviving and nonsurviving groups according to 28-day mortality.There were significant differences in the Acute Physiologic Assessment and Chronic Health Evaluation Ⅱ scores,Sequential Or-gan Failure Assessment scores,MLRs,and LARs between the surviving and nonsurviving groups.The AUC for the LAR was 0.790(P＜0.001),whereas the AUCs for the Acute Physiologic Assessment and Chronic Health Evaluation Ⅱ score,Sequential Organ Failure Assessment score,neutrophil-to-lymphocyte ratio,and MLR were 0.584,0.599,0.524,and 0.587,respectively.After grouping according to an LAR optimal cutoff value of 0.07,28-day mortality was significantly higher in the high-LAR group than in the low-LAR group(47.18 vs.12.69,P＜0.001). Conclusion:The LAR is an independent risk factor for 28-day mortality in ARDS patients and can be used to assess the severity of ARDS to a certain extent,making it superior to other commonly used indicators.